| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -53.51 | -118.29 | -106.10 | -39.54 |
| Net Changein Cash | -0.58 | 2.23 | -0.23 | -7.73 |
| Cash Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income/ Starting Line | -161.53 | 18.27 | -42.42 | 34.08 |
| Changesin Working Capital | 191.95 | 68.87 | 77.93 | -64.54 |
| Cashfrom Operating Activities | 169.44 | 224.69 | 133.65 | 95.01 |
| Cash Interest Paid | 74.58 | 87.14 | 79.49 | 78.81 |
| Cashfrom Financing Activities | -128.09 | -205.44 | -185.58 | -119.38 |
| Depreciation/ Depletion | 62.39 | 60.72 | 59.12 | 56.97 |
| Other Investing Cash Flow Items Total | 1.86 | 12.39 | 81.76 | 41.61 |
| Capital Expenditures | -43.80 | -29.42 | -30.06 | -24.97 |
| period Type | - | - | - | - |
| Non- Cash Items | 76.63 | 76.83 | 39.03 | 68.50 |
| Financing Cash Flow Items | -74.58 | -87.14 | -79.49 | -78.81 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -41.93 | -17.03 | 51.70 | 16.64 |
| Total Cash Dividends Paid | - | - | - | -1.03 |
Nectar Lifesciences Dividend Nectar Lifesciences Bonus Nectar Lifesciences News Nectar Lifesciences AGM Nectar Lifesciences Rights Nectar Lifesciences Splits Nectar Lifesciences Board Meetings Nectar Lifesciences Key Metrics Nectar Lifesciences Shareholdings Nectar Lifesciences Profit Loss Nectar Lifesciences Balance Sheet Nectar Lifesciences Q1 Results Nectar Lifesciences Q2 Results Nectar Lifesciences Q3 Results Nectar Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.